SCM
PBMWW

Saba Capital Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Saba Capital Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.41K Hold
297,847
– – ﹤0.01% 368
2025
Q4 		$4.71K Hold
297,847
– – ﹤0.01% 326
2025
Q3 		$7.51K Hold
297,847
– – ﹤0.01% 298
2025
Q2 		$6.03K Hold
297,847
– – ﹤0.01% 295
2025
Q1 		$5.05K Hold
297,847
– – ﹤0.01% 242
2024
Q4 		$4.14K Hold
297,847
– – ﹤0.01% 264
2024
Q3 		$3.75K Hold
297,847
– – ﹤0.01% 323
2024
Q2 		$4.41K Hold
297,847
– – ﹤0.01% 351
2024
Q1 		$21.3K Buy
+297,847
New +$18.6K ﹤0.01% 303

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return